Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Rat (Rattus) ZNRF3 Antibodies:
anti-Human ZNRF3 Antibodies:
anti-Mouse (Murine) ZNRF3 Antibodies:
Go to our pre-filtered search.
Report shows that miR (show MLXIP Antibodies)-146b participated in migration, invasion and chemoresistance in osteosarcoma via downregulation of ZNRF3.
Data indicate Dishevelled (DVL (show DVL2 Antibodies)) as a dual function adaptor to recruit negative regulators ZNRF3/RNF43 (show RNF43 Antibodies) to Wnt (show WNT2 Antibodies) receptors to ensure proper control of pathway activity.
ZNRF3 binds RSPO1 (show RSPO1 Antibodies) and LGR5 (show LGR5 Antibodies)-RSPO1 (show RSPO1 Antibodies) with micromolar affinity via RSPO1 (show RSPO1 Antibodies) furin (show FURIN Antibodies)-like 1 (Fu1) domain.
Genes within recently identified loci associated with waist-hip ratio (WHR) exhibit fat depot-specific mRNA expression, which correlates with obesity-related traits. Adipose tissue (AT) mRNA expression of 6 genes (TBX15 (show TBX15 Antibodies)/WARS2 (show WARS2 Antibodies), STAB1 (show STAB1 Antibodies), PIGC (show PIGC Antibodies), ZNRF3, GRB14 (show GRB14 Antibodies)
Signalling potency of R-spondin proteins depends on their ability to recruit ZNRF3 or RNF43 (show RNF43 Antibodies) via Fu1 into a complex with LGR receptors, which interact with Rspo (show RSPO1 Antibodies) via Fu2
ZNRF3 inhibits gastric cancer cell growth and promotes cell apoptosis by affecting the Wnt (show WNT2 Antibodies)/beta-catenin (show CTNNB1 Antibodies)/TCF4 (show TCF4 Antibodies) signalling pathway.
study provides new mechanistic insights (show WNT2 Antibodies)into the regulation of Wnt receptor turnover, and reveals ZNRF3 as a tractable target for therapeutic exploration
Crystal structure confirming that Rspo (show RSPO1 Antibodies) proteins cross-link LGRs and ZNRF3 into a 2:2:2 complex.
data suggest that R-spondin enhances Wnt (show WNT2 Antibodies) signalling by inhibiting ZNRF3
E3 ubiquitin-protein ligase that acts as a negative regulator of the Wnt signaling pathway by mediating the ubiquitination and subsequent degradation of Wnt receptor complex components Frizzled and LRP6. Acts on both canonical and non- canonical Wnt signaling pathway.
, E3 ubiquitin-protein ligase ZNRF3
, RING finger protein 203
, novel C3HC4 type Zinc finger (ring finger)
, zinc/RING finger protein 3